Phase Three Trials
-
{
- All
- News
- Videos
-
New Tuberculosis Vaccines: Phase 3 Study Confirms Safety, But It May Not Protect Against All Forms Of Infection
The two new tuberculosis vaccines could be safe for use in adults and children in India but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial results published in The British Medical Journal.
-
'Positive' Trial For Pfizer-BioNTech Covid-Flu Jab
"A pivotal phase three trial evaluating these lead formulations is expected to be initiated in the coming months," they said.
-
No Scientific Body Suggests Kids' Vaccination For School Opening: Centre
Hyderabad-based Biological E Limited has been given permission to conduct the phase two/three clinical trial of its indigenously developed COVID-19 vaccine on children and adolescents aged between five and 18 years with certain conditions.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Haryana Minister Anil Vij To Be Administered Trial Dose Of COVID Vaccine Covaxin
Haryana Health Minister Anil Vij who had offered to be the first volunteer in the phase three trials for Covaxin, a potential vaccine against COVID-19, will get the dose on Friday.
-
Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India
Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial.
-
Only 3 COVID-19 Vaccine Candidate In Phase 3 Across The Globe: Centre
In the development related to the COVID-19 vaccine across the world, only three vaccine candidates are in phase III clinical trials across the globe. These three coronavirus vaccine candidates are from the USA, UK (University of Oxford's vaccine) and China, informed the official from the Union Health Ministry on Thursday.
-
Sun Mobility And Smart E Partner For Battery Technology
Sun Mobility and Smart E have entered into a strategic partnership to develop a new EV battery swapping system. Earlier this year, Sun mobility had showcased the interoperable smart mobility solution for two and three wheelers. SmartE's fleet of electric three-wheelers will make use of SUN Mobility's solution and will be deployed at SmartE park & c...
-
New Drug Found More Effective for Chronic Leukemia Patients
Older adults with chronic lymphocytic leukemia, a type of slow-growing blood cancer, may have a better alternative to toxic chemotherapy as their first treatment, results of a phase three clinical trial show.
-
Convicted Boston Bomber Dzhokhar Tsarnaev's Death Penalty Phase to Begin April 21
The Boston Marathon bombing trial enters a new phase on April 21 as federal prosecutors begin to mount their case for putting Dzhokhar Tsarnaev to death for killing three people and injuring 264 others in the 2013 attack.
-
New Tuberculosis Vaccines: Phase 3 Study Confirms Safety, But It May Not Protect Against All Forms Of Infection
The two new tuberculosis vaccines could be safe for use in adults and children in India but may not provide protection against all forms of the infectious bacterial disease, according to phase-3 trial results published in The British Medical Journal.
-
'Positive' Trial For Pfizer-BioNTech Covid-Flu Jab
"A pivotal phase three trial evaluating these lead formulations is expected to be initiated in the coming months," they said.
-
No Scientific Body Suggests Kids' Vaccination For School Opening: Centre
Hyderabad-based Biological E Limited has been given permission to conduct the phase two/three clinical trial of its indigenously developed COVID-19 vaccine on children and adolescents aged between five and 18 years with certain conditions.
-
Vaccine's Restricted Use Considered Based On Safety Data: Medical Body Chief
In a pandemic situation, restricted emergency use of vaccines is considered based on safety and immunogenicity data while phase three clinical trial is underway, Indian Council of Medical Research (ICMR) Chief Balram Bhargava said on Tuesday.
-
Haryana Minister Anil Vij To Be Administered Trial Dose Of COVID Vaccine Covaxin
Haryana Health Minister Anil Vij who had offered to be the first volunteer in the phase three trials for Covaxin, a potential vaccine against COVID-19, will get the dose on Friday.
-
Serum Institute Gets Nod To Resume Oxford COVID-19 Vaccine Trial In India
Drugs Controller General of India (DCGI) Dr VG Somani on Tuesday gave permission to Serum Institute of India to resume clinical trial of the Oxford COVID-19 vaccine candidate in the country while revoking its earlier order of suspending any new recruitment for phase two and three trial.
-
Only 3 COVID-19 Vaccine Candidate In Phase 3 Across The Globe: Centre
In the development related to the COVID-19 vaccine across the world, only three vaccine candidates are in phase III clinical trials across the globe. These three coronavirus vaccine candidates are from the USA, UK (University of Oxford's vaccine) and China, informed the official from the Union Health Ministry on Thursday.
-
Sun Mobility And Smart E Partner For Battery Technology
Sun Mobility and Smart E have entered into a strategic partnership to develop a new EV battery swapping system. Earlier this year, Sun mobility had showcased the interoperable smart mobility solution for two and three wheelers. SmartE's fleet of electric three-wheelers will make use of SUN Mobility's solution and will be deployed at SmartE park & c...
-
New Drug Found More Effective for Chronic Leukemia Patients
Older adults with chronic lymphocytic leukemia, a type of slow-growing blood cancer, may have a better alternative to toxic chemotherapy as their first treatment, results of a phase three clinical trial show.
-
Convicted Boston Bomber Dzhokhar Tsarnaev's Death Penalty Phase to Begin April 21
The Boston Marathon bombing trial enters a new phase on April 21 as federal prosecutors begin to mount their case for putting Dzhokhar Tsarnaev to death for killing three people and injuring 264 others in the 2013 attack.
